Submitted by Anonymous (not verified) on 6 February 2026 - 15:00
Human medicines European public assessment report (EPAR): Bildyos, denosumab, Date of authorisation: 17/09/2025, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Bildyos, denosumab, Date of authorisation: 17/09/2025, Revision: 3, Status: Authorised